Aging Population is
Inciting the #Health-tech Industry to Create Innovative Solutions (ASX: $COH.AX)
(OTCQB: $INND) (OTC: $GNBT) (NASDAQ: $ONVO)
Point
Roberts, WA and Delta, BC - April 24, 2019 (Investorideas.com Newswire) Investorideas.com, a leading
investor news resource covering technology and healthcare stocks releases a
snapshot looking at how the growing global aging population is inciting the
health-tech industry to create innovative solutions to address growing concerns
affecting this demographic, whether through hearing aids, oral aids or CBD oil.
According to Acumen Research and Consulting, the global Ear-Nose-Throat
(ENT) devices market is forecast to grow at a stable CAGR
around 8% during the period 2018 to 2026. In the report named “Ear-Nose-Throat
(ENT) Devices Market” - Global Industry Analysis, Growth, Share, Size, Trends
and Forecast, 2018-2026”, rising incorporation of advanced technology, growing
awareness about various health related issues, ever-increasing healthcare
costs, favorable regulatory backdrop for ENT devices, increasing geriatric
population, technological advancements, user-friendly ENT devices changing
lifestyle patterns and ease of availability of various ear-nose-throat devices
are some of the key factors that are fuelling the ear-nose-throat devices
market growth across the globe.
This was reaffirmed in the The
State of Hearing Report conducted
for Cochlear Limited (ASX: COH), which revealed that many people know that adults with hearing loss are
facing social isolation, declining self-esteem and losing the ability to
communicate as their families feel the strain and that a solution could start
by people simply changing how they think about hearing loss and recognizing it
can often be preventable and treatable.
InnerScope
Hearing Technologies Inc. (OTCQB: INND), a manufacturer and Direct-to-Consumer
distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifier
Products, Hearing Related Treatment
Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary
CBD Oil, recently announced that it has entered into an Agreement with AsSeenOnTV.pro to produce Direct Response TV and Brand
Response TV commercials promoting its Self-Fitting Hearing Aids (“NEXUS”),
Dietary Hearing Supplements “Nutrition for the Ears” and CBD Oil. The Hearing
Product Commercials will feature Kevin
Harrington, the pioneer of the
‘As Seen On TV’ empire and an original “Shark” from the Emmy award-winning TV
reality show, Shark Tank. Kevin
Harrington is also the Co-Executive Producer and the mastermind behind
AsSeenOnTV.pro DRTV/BRTV campaigns.
Mr. Harrington
commented “Having known and worked with the founders of InnerScope in the past,
I know their passion and expertise in helping the tens of millions of people
that have hearing related problems. With
48 million people in the US alone that have reported having hearing issues,
InnerScope’s Hearing Aids and Hearing Health Products have mass-market appeal.
This is one of the reasons my team thinks InnerScope is a good fit to create an
Omni-Channel TV/Video Media Campaign to target those tens of millions potential
customers.”
Generex Biotechnology Corporation (OTC: GNBT), who, through its subsidiaries engages in the administration of
formulations of large molecule drugs to the oral cavity, recently announced that the company’s subsidiary Olaregen
Therapeutix participated as a sponsor of the prestigious Diabetic Limb Salvage
Conference in Washington, DC as part of its continued commitment to Wound Care
Education. The Conference was attended by 600 influential experts and
healthcare providers involved in the research and management of wounds, with
specific emphasis on diabetic foot ulcers (DFUs). Olaregen hosted an exhibit to
present information on its now commercial wound care product, Excellagen®,
formulated fibrillar collagen (2.6%) wound conforming matrix, indicated for the
management of several wound types, significant among them, DFUs.
Organovo Holdings, Inc. (NASDAQ: ONVO), a biotechnology company pioneering the
development of 3D bio-printed tissues aimed at treating a range of serious
adult and pediatric liver diseases, announced that Chief Medical Officer, Dr. Steven G.
Hughes is scheduled to speak at the inaugural Cell & Gene Meeting on the
Mediterranean to be held April 23-25 in Barcelona, Spain.
This event, modeled
after The Alliance for Regenerative Medicine’s (“ARM”) highly successful Cell
& Gene Meeting on the Mesa held annually in La Jolla, California, is
expected to attract more than 250 attendees, including senior executives from
leading cell therapy, gene therapy, and tissue engineering companies worldwide,
large pharma and biotech representatives, institutional investors, academic
research institutions, patient foundations, disease philanthropies and members
of the life science media community.
This “new age trend”
of focusing on awareness and access with regards to healthcare technology for
this expanding, aging population is proving to be a valued component for the
industry. It’s now “good business” to care for our elders.
For investors
following medical technology and healthcare stocks, Investor Ideas has created a directory of biotech and medical technology
stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in AI.
Follow us on Social Media
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: this news article featuring InnerScope Hearing Technologies is a paid for service on
Investorideas.com(third party)
Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment